A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components - No Study Results Posted

A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components (MARS)

This study has been completed.

Study NCT00819104 Information provided by AstraZeneca

First Received: January 7, 2009 Last Updated: September 7, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2009
Estimated Primary Completion Date:	No date given